{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:24:36Z","timestamp":1794936276470,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-09540-0","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:47:11Z","timestamp":1782827231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating progestin-primed and GnRH antagonist ovarian stimulation protocols in PGT-A cycles: implications for clinical practice"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7977-4364","authenticated-orcid":false,"given":"Burak","family":"Elmas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-4747","authenticated-orcid":false,"given":"Ozge","family":"Karaosmanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7065-6588","authenticated-orcid":false,"given":"Aysen","family":"Yuceturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-8354","authenticated-orcid":false,"given":"Ilke Ozer","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7049-8522","authenticated-orcid":false,"given":"Burcu Aksu","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-3851","authenticated-orcid":false,"given":"Nuri","family":"Peker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2323-3037","authenticated-orcid":false,"given":"Omur","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-4312","authenticated-orcid":false,"given":"Hakan","family":"Berkil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-3332","authenticated-orcid":false,"given":"Bulent","family":"Tiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"1","key":"9540_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12884-025-07247-2","volume":"25","author":"SF Fattahpour","year":"2025","unstructured":"Fattahpour SF, Hakimi P, Tabatabaei F, Hejazad M, Amoozadeh M, Sadeghi L, Rezaie N, Vejdani R, Azizi H. Comparison of live birth rate and fetal outcomes between fresh embryo and frozen-thawed embryo transfers: a prospective study. BMC Pregnancy Childbirth. 2025;25(1):122. https:\/\/doi.org\/10.1186\/s12884-025-07247-2.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"9540_CR2","doi-asserted-by":"publisher","first-page":"CD011184","DOI":"10.1002\/14651858.CD011184.pub2","volume":"3","author":"KM Wong","year":"2017","unstructured":"Wong KM, van Wely M, Mol F, Repping S, Mastenbroek S. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev. 2017;3(3):CD011184. https:\/\/doi.org\/10.1002\/14651858.CD011184.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"9540_CR3","doi-asserted-by":"publisher","first-page":"m2519","DOI":"10.1136\/bmj.m2519","volume":"370","author":"S Stormlund","year":"2020","unstructured":"Stormlund S, Sopa N, Zedeler A, Bogstad J, Pr\u00e6torius L, Svarre Nielsen H, et al. Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation in women with regular menstrual cycles: multicentre randomised controlled trial. BMJ. 2020;370:m2519. https:\/\/doi.org\/10.1136\/bmj.m2519.","journal-title":"BMJ"},{"issue":"1","key":"9540_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62\u201370. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.03.022.","journal-title":"Fertil Steril"},{"issue":"1","key":"9540_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","volume":"27","author":"B Ata","year":"2021","unstructured":"Ata B, Capuzzo M, Turkgeldi E, Yildiz S, La Marca A. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses. Hum Reprod Update. 2021;27(1):48\u201366. https:\/\/doi.org\/10.1093\/humupd\/dmaa040.","journal-title":"Hum Reprod Update"},{"key":"9540_CR6","doi-asserted-by":"publisher","unstructured":"Wang M, Zheng L, Ma S, Xu Y, Zhang J, Fu L. A comparison of the effects of progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in assisted reproductive technology: a systematic review and meta-analysis. J Assist Reprod Genet. 2025 Aug;7. https:\/\/doi.org\/10.1007\/s10815-025-03612-4.","DOI":"10.1007\/s10815-025-03612-4"},{"issue":"4","key":"9540_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00404-023-07269-1","volume":"309","author":"R Deng","year":"2024","unstructured":"Deng R, Wang J, He J, Lei X, Zi D, Nong W, et al. GnRH antagonist protocol versus progestin-primed ovarian stimulation in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Arch Gynecol Obstet. 2024;309(4):1151\u201363. https:\/\/doi.org\/10.1007\/s00404-023-07269-1.","journal-title":"Arch Gynecol Obstet"},{"key":"9540_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fnins.2013.00099","volume":"7","author":"JJ Peluso","year":"2013","unstructured":"Peluso JJ. Progesterone receptor membrane component 1 and its role in ovarian follicle growth. Front Neurosci. 2013;7:99. https:\/\/doi.org\/10.3389\/fnins.2013.00099.","journal-title":"Front Neurosci"},{"key":"9540_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jare.2021.02.008","volume":"33","author":"H Long","year":"2021","unstructured":"Long H, Yu W, Yu S, Li R, Chang H, Liu Y, et al. Progesterone affects clinic oocyte yields by coordinating with follicle stimulating hormone via PI3K\/AKT and MAPK pathways. J Adv Res. 2021;33:189\u201399. https:\/\/doi.org\/10.1016\/j.jare.2021.02.008.","journal-title":"J Adv Res"},{"issue":"4","key":"9540_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.fertnstert.2022.06.012","volume":"118","author":"H Chen","year":"2022","unstructured":"Chen H, Teng XM, Sun ZL, Yao D, Wang Z, Chen ZQ. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study. Fertil Steril. 2022;118(4):701\u201312. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.06.012.","journal-title":"Fertil Steril"},{"issue":"5","key":"9540_CR11","doi-asserted-by":"publisher","first-page":"104349","DOI":"10.1016\/j.rbmo.2024.104349","volume":"49","author":"L Wan","year":"2024","unstructured":"Wan L, Chen F, Xiong D, Li X, Zhou Y, Zhou W, et al. Comparison of aneuploidy for patients of different ages treated with progestin-primed ovarian stimulation or GnRH antagonist protocols. Reprod Biomed Online. 2024;49(5):104349. https:\/\/doi.org\/10.1016\/j.rbmo.2024.104349.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"9540_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","volume":"21","author":"AH Pai","year":"2023","unstructured":"Pai AH, Sung YJ, Li CJ, Su JT, Wu MH, Tsai HD, et al. Progestin primed ovarian stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF. Reprod Biol Endocrinol. 2023;21(1):72. https:\/\/doi.org\/10.1186\/s12958-023-01124-3.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"9540_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40001-023-01000-1","volume":"28","author":"L Wang","year":"2023","unstructured":"Wang L, Wang JY, Zhang Y, Qian C, Wang XH, Ng EHY, et al. Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist\/antagonist protocol. Eur J Med Res. 2023;28(1):28. https:\/\/doi.org\/10.1186\/s40001-023-01000-1.","journal-title":"Eur J Med Res"},{"issue":"6","key":"9540_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","volume":"35","author":"A La Marca","year":"2020","unstructured":"La Marca A, Capuzzo M, Sacchi S, Imbrogno MG, Spinella F, Varricchio MT, et al. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation. Hum Reprod. 2020;35(6):1325\u201331. https:\/\/doi.org\/10.1093\/humrep\/deaa068.","journal-title":"Hum Reprod"},{"issue":"3","key":"9540_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","volume":"109","author":"Practice Committees of the American Society for Reproductive Medicine; Society for Assisted Reproductive Technology","year":"2018","unstructured":"Practice Committees of the American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril. 2018;109(3):429\u201336. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.01.002.","journal-title":"Fertil Steril"},{"issue":"1","key":"9540_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/a-1876-2231","volume":"83","author":"M Kljajic","year":"2023","unstructured":"Kljajic M, Saym\u00e9 N, Krebs T, Wagenpfeil G, Baus S, Solomayer EY, et al. Zygote diameter and total cytoplasmic volume as useful predictive tools of blastocyst quality. Geburtshilfe Frauenheilkd. 2023;83(1):97\u2013105. https:\/\/doi.org\/10.1055\/a-1876-2231.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"9540_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/humrep\/deae012","volume":"39","author":"MDM Vidal","year":"2024","unstructured":"Vidal MDM, Mart\u00ednez F, Rodr\u00edguez I, Polyzos NP. Ovarian response and embryo ploidy following progesterone-primed versus antagonist protocol. Hum Reprod. 2024;39(5):1098\u2013104. https:\/\/doi.org\/10.1093\/humrep\/deae012.","journal-title":"Hum Reprod"},{"issue":"1","key":"9540_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12905-025-03601-w","volume":"25","author":"Q Sun","year":"2025","unstructured":"Sun Q, Cao Y, Gu J, Xu Y. The application of progesterone-primed ovarian stimulation protocol in patients with ovarian endometriosis combined with diminished ovarian reserve. BMC Womens Health. 2025;25(1):70. https:\/\/doi.org\/10.1186\/s12905-025-03601-w.","journal-title":"BMC Womens Health"},{"issue":"1","key":"9540_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12958-025-01234-5","volume":"23","author":"H Tan","year":"2025","unstructured":"Tan H, Huang L, Liu W, Yan J, Li L, Wang Y, et al. Euploidy rate and pregnancy outcomes in PGT-A cycles using PPOS versus GnRH antagonist protocol. Reprod Biol Endocrinol. 2025;23(1):73. https:\/\/doi.org\/10.1186\/s12958-025-01234-5.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"9540_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12958-025-01189-7","volume":"23","author":"L Wang","year":"2025","unstructured":"Wang L, Wang JY, Zhang Y, Qian C, Wang XH, Ng EHY, et al. Comparison of euploidy rate in PGT-A cycles following PPOS vs GnRH antagonist protocol: a randomized controlled study. Reprod Biol Endocrinol. 2025;23(1):67. https:\/\/doi.org\/10.1186\/s12958-025-01189-7.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"9540_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.fertnstert.2020.10.051","volume":"115","author":"EG Jaswa","year":"2021","unstructured":"Jaswa EG, McCulloch CE, Simbulan R, Cedars MI, Rosen MP. Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity. Fertil Steril. 2021;115(4):966\u201373. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.10.051.","journal-title":"Fertil Steril"},{"issue":"6","key":"9540_CR22","doi-asserted-by":"publisher","first-page":"103366","DOI":"10.1016\/j.rbmo.2023.103366","volume":"47","author":"W Fu","year":"2023","unstructured":"Fu W, Cui Q, Yang Z, Bu Z, Shi H, Bi B, et al. High sperm DNA fragmentation increased embryo aneuploidy rate in patients undergoing preimplantation genetic testing. Reprod Biomed Online. 2023;47(6):103366. https:\/\/doi.org\/10.1016\/j.rbmo.2023.103366.","journal-title":"Reprod Biomed Online"},{"key":"9540_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10815-019-01673-w","volume":"37","author":"S Kahraman","year":"2020","unstructured":"Kahraman S, Sahin Y, Yelke H, Kumtepe Y, Tufekci MA, Yapan CC, et al. High rates of aneuploidy, mosaicism and abnormal morphokinetic development in cases with low sperm concentration. J Assist Reprod Genet. 2020;37:629\u201340. https:\/\/doi.org\/10.1007\/s10815-019-01673-w.","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 1","key":"9540_CR24","doi-asserted-by":"publisher","first-page":"dead093611","DOI":"10.1093\/humrep\/dead093.611","volume":"38","author":"T Laguna Rodriguez","year":"2023","unstructured":"Laguna Rodriguez T, Serrano Molina M, Romero Olmedo MDSL, De Andr\u00e9s Cara M, Rico Nieto E, Fern\u00e1ndez Gonz\u00e1lez MJ, et al. Clinical efficacy of PGT-A according to maternal age and embryo quality in blastocyst stage. Hum Reprod. 2023;38(Suppl 1):dead093611. https:\/\/doi.org\/10.1093\/humrep\/dead093.611.","journal-title":"Hum Reprod"},{"issue":"3","key":"9540_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/humrep\/del445","volume":"22","author":"J Smitz","year":"2007","unstructured":"Smitz J, Andersen AN, Devroey P, Arce JC, MERIT Group. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod. 2007;22(3):676\u201387. https:\/\/doi.org\/10.1093\/humrep\/del445.","journal-title":"Hum Reprod"},{"issue":"4","key":"9540_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/humupd\/dmu011","volume":"20","author":"A Kasius","year":"2014","unstructured":"Kasius A, Smit JG, Torrance HL, Eijkemans MJC, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review. Hum Reprod Update. 2014;20(4):530\u201341. https:\/\/doi.org\/10.1093\/humupd\/dmu011.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"9540_CR27","doi-asserted-by":"publisher","first-page":"e0239120","DOI":"10.1371\/journal.pone.0239120","volume":"15","author":"Z Shaodi","year":"2020","unstructured":"Shaodi Z, Qiuyuan L, Yisha Y, Cuilian Z. The effect of endometrial thickness on pregnancy outcomes of frozen-thawed embryo transfer cycles which underwent hormone replacement therapy. PLoS ONE. 2020;15(9):e0239120. https:\/\/doi.org\/10.1371\/journal.pone.0239120.","journal-title":"PLoS ONE"},{"issue":"4","key":"9540_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ajog.2018.11.1103","volume":"220","author":"M Irani","year":"2019","unstructured":"Irani M, Zaninovic N, Rosenwaks Z, Xu K. Does maternal age at retrieval influence the implantation potential of euploid blastocysts? Am J Obstet Gynecol. 2019;220(4):379. e1-379.e7.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"9540_CR29","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00404-025-08229-7","volume":"312","author":"YA Tohma","year":"2025","unstructured":"Tohma YA, Boynukal\u0131n FK, G\u00fcltomruk M, Bah\u00e7eci M, Bozda\u011f G. GnRH agonist trigger in focus: does protocol choice between PPOS and antagonist strategies affect outcomes? Arch Gynecol Obstet. 2025;312(6):2303\u20139. https:\/\/doi.org\/10.1007\/s00404-025-08229-7.","journal-title":"Arch Gynecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09540-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:54:56Z","timestamp":1785941696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09540-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9540"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09540-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Institutional Review Board of Acibadem Mehmet Ali Aydinlar University (Approval No: 2025-10\/382, Date: 26.06.2025). The study was conducted in accordance with the Declaration of Helsinki and relevant national regulations. Written informed consent for treatment was obtained from all participants at the time of their clinical procedures. Due to the retrospective design of the study and the use of fully anonymized data, additional informed consent for participation in this research was waived by the Ethics Committee. Patient confidentiality was strictly maintained, and all data were analyzed anonymously with institutional permission.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"843"}}